Editors
Editor (Adis International Limited, Auckland, New Zealand):
Ms Sue Pochon, BSc. Adis International Limited, Auckland, New Zealand
Section Editors (Adis International Limited, Auckland, New Zealand):
Dr Martin Chopra, PhD BSc. Adis International Limited, Auckland, New Zealand
Dr Alison Fitches, PhD BSc. Adis International Limited, Auckland, New Zealand
Ms Kathy Fraser, DipPharm. Adis International Limited, Auckland, New Zealand
Ms Caroline Herdson, BSc. Adis International Limited, Auckland, New Zealand
Dr Rod McNab, PhD BSc. Adis International Limited, Auckland, New Zealand
Dr Alma Orts-Sebastian, PhD MS BPharm. Adis International Limited, Auckland, New Zealand
Dr Dene Peters, BVSc. Adis International Limited, Auckland, New Zealand
Dr Amitabh Prakash, MD MBBS. Adis International Limited, Auckland, New Zealand
Editors Emeriti:
Professor Anthony W. Fox, MSc MBBS MD FFPM FRCP DipPharmMed MCSFS DipFHI MFMLM CBiol. King's College London, London, UK
Dr Shaun Kilminster, BSc(Hon) PGCEd MSc(Psych) CPsychol PhD FSS Hon FFPM. Institute of Naval Medicine, Alverstoke, UK
Dr Noel Snell, FRCP FFPM FRIPH FIBiol. National Heart & Lung Institute, London, UK
Editorial board members:
Dr Peter R. Arlett, MD MRCP. European Medicines Agency, Amsterdam, the Netherlands
Dr Sander Becker, MD. Consultants in Pharmaceutical Medicine, Rose Bay North, NSW, Australia
Dr Alexander Bedenkov, PhD. AstraZeneca, Cambridge, UK
Dr Ambrogio Bottoni, MD. Pfizer Inc., Milan, Italy
Dr Torbjӧrn Callréus, MD PhD. Malta Medicines Authority, San Ġwann, Malta
Dr Norbert Clemens, MD PhD CPI. Association of Clinical Research Professionals Academy Board of Trustees, Heidelberg, Germany
Mr Francis P. Crawley, PhL. Good Clinical Practice Alliance – Europe, Brussels, Belgium
Dr Jean-Paul Deslypere, MD PhD. Council on Education in Pharmaceutical Medicine, Singapore
Dr Francesco De Tomasi, MD. Italian Society of Pharmaceutical Medicine, Milan, Italy
Dr Georg Ferber, PhD. Statistik Georg Ferber GmbH, Riehen, Switzerland
Dr Claudio Fracasso, MD. Pfizer S.r.l., Rome, Italy
Professor Sanjay K. Garg, PhD. University of South Australia, Adelaide, SA, Australia
Dr E. Stewart Geary, MD. Eisai Co. Ltd., Tokyo, Japan
Mr Kenneth A. Getz, MBA. Tufts University Medical School, Boston, MA, USA
Mr Ari Gnanasakthy, BSc MSc MBA. RTI Health Solutions, Research Triangle Park, NC, USA
Dr Ulrich Granzer, PhD. Granzer Regulatory Consulting & Services, Munich, Germany
Professor Jan D. Hirsch, BSPharm PhD. University of California, Irvine, CA, USA
Dr Ambrose O. Isah, MD. University of Benin, Benin, Nigeria, Africa
Dr Greg Koski, MD PhD CPI. Alliance for Clinical Research Excellence and Safety, Cambridge, MA, USA
Dr Marlene Llopíz Avíles, BA MD MPH. Association of Medical Specialists in the Pharmaceutical Industry, Mexico City, Mexico
Dr Marcelo Marotti, MD PhD. Boehringer Ingelheim, Ingelheim am Rhein, Germany
Dr Peter G. M. Mol, PhD, PharmD. Dutch Medicines Evaluation Board, Utrecht, the Netherlands
Dr Shunsuke Ono, PhD. University of Tokyo, Tokyo, Japan
Dr María Proupín-Pérez, PhD. CSL Behring Innovation GmbH, Marburg, Germany
Dr Klaus Rose, MD MS. Klausrose Consulting, Riehen, Switzerland
Professor Sam Salek, BPharm PhD RPh MRPSGB FFPM FESCP. University of Hertfordshire, Hatfield, UK
Professor Grannum R. Sant, MD FRCS FACS. Tufts University School of Medicine, Boston, MA, USA
Dr Ruth Savage, MB BS MSc. University of Otago, Dunedin, New Zealand
Dr Jeffrey W. Sherman, MD FACP. Horizon Pharma, Deerfield, IL, USA
Dr Honorio Silva, MD. International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine, New York, NY, USA
Professor Peter D. Stonier, BA BSc PhD MB ChB MRCPsych FRCP FRCPE FFPM. King’s College London, London, UK
Dr Robert Temple, MD. Center for Drug Evaluation & Research, Food and Drug Administration, Rockville, MD, USA
Professor Rolf Teschke, MD. Klinikum Hanau, Hanau, Germany
Professor Stuart R. Walker, BSc PhD CChem CBiol FRSC FIBiol FInstD FRCPath. Centre for Innovation in Regulatory Science, Carshalton, UK